Dr. Stein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
333 Cedar St
Box 208028
New Haven, CT 06510Phone+1 203-785-5756Fax+1 203-200-6950
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Rutgers Robert Wood Johnson Medical SchoolClass of 2004
Certifications & Licensure
CT State Medical License 2010 - 2025
NY State Medical License 2007 - 2010- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Start of enrollment: 2009 Oct 28
- Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Start of enrollment: 2014 Feb 01
- Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer Start of enrollment: 2017 Jan 01
Publications & Presentations
PubMed
- 350 citationsAtezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.Michael S. Lee, Baek Yeol Ryoo, Chih-Hung Hsu, Kazushi Numata, Stacey Stein
The Lancet. Oncology. 2020-06-01 - 29 citationsSafety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.Samuel J. Klempner, Johanna C. Bendell, Victoria M. Villaflor, Laura LaNiel Tenner, Stacey Stein
Molecular Cancer Therapeutics. 2021-09-04 - 151 citationsFinal analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancerStacey Stein, Edward Samuel James, Yanhong Deng, Xiangyu Cong, Jeremy S. Kortmansky
British Journal of Cancer. 2016-03-01
Lectures
- Association of real-world agreement between HER2 expression and ERBB2 amplification with trastuzumab therapy benefit in advanced gastric/esophageal (adv GE) cancer pat...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC).2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
Dr. Stacey Stein and Dr. Neal Fischbach Appointed as Assistant Medical Directors at Yale Cancer Center Clinical Trials OfficeOctober 15th, 2021
New Investigation into PD-1 Blockade for Hepatocellular CarcinomaJanuary 10th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
